XML 50 R35.htm IDEA: XBRL DOCUMENT v3.20.2
Equity (Tables)
9 Months Ended
Sep. 30, 2020
Equity  
Schedule of stock based compensation expense

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

(in millions)

    

2020

    

2019

    

2020

    

2019

 

Stock options:

Pre-tax compensation expense

 

$

1

 

$

 

$

3

$

2

Income tax benefit

 

 

 

 

Stock option expense, net of income taxes

 

1

 

 

3

 

2

Restricted stock units ("RSUs"):

Pre-tax compensation expense

 

3

 

2

 

9

 

7

Income tax benefit

 

 

 

(1)

 

(1)

RSUs, net of income taxes

 

3

 

2

 

8

 

6

Performance shares and other share-based awards:

Pre-tax compensation expense

 

2

 

2

 

6

 

5

Income tax benefit

 

(1)

 

 

(1)

 

Performance shares and other share-based compensation expense, net of income taxes

 

1

 

2

 

5

 

5

Total share-based compensation:

Pre-tax compensation expense

 

6

 

4

 

18

 

14

Income tax benefit

 

(1)

 

 

(2)

 

(1)

Total share-based compensation expense, net of income taxes

 

$

5

 

$

4

 

$

16

$

13

Schedule of valuation assumptions for stock options

Nine Months Ended September 30, 

    

2020

2019

Expected life (in years)

5.5

5.5

Risk-free interest rate

1.4

%

2.5

%

 

Expected volatility

19.8

%

19.7

%

Expected dividend yield

2.9

%

2.7

%

Schedule of stock option transactions

    

Number of Options (in thousands)

    

Weighted Average Exercise Price per Share

    

Average Remaining Contractual Term (Years)

    

Aggregate Intrinsic Value (in millions)

 

Outstanding as of December 31, 2019

 

2,055

 

$

84.36

5.30

$

34

Granted

 

336

88.35

Exercised

 

(93)

45.12

Cancelled

 

(19)

85.75

Outstanding as of September 30, 2020

 

2,279

$

86.55

 

5.37

 

$

12

Exercisable as of September 30, 2020

 

1,740

$

84.09

 

4.33

 

$

12

Schedule of additional information pertaining to stock option activity

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

(dollars in millions, except per share)

    

2020

    

2019

    

2020

    

2019

  

Weighted average grant date fair value of stock options granted (per share)

$

$

$

11.48

$

14.02

Total intrinsic value of stock options exercised

$

$

1

$

4

$

7

Schedule of restricted unit activity

(RSUs in thousands)

    

Number of Restricted Shares

    

Weighted Average Fair Value per Share

Non-vested as of December 31, 2019

339

$

108.02

Granted

178

88.10

Vested

(92)

117.18

Cancelled

(14)

102.71

Non-vested as of September 30, 2020

411

$

97.52

Summary of net changes in accumulated other comprehensive loss

(in millions)

    

Cumulative Translation Adjustment

    

Hedging Activities

    

Pension and Postretirement Adjustment

    

Accumulated Other Comprehensive Loss

   

Balance, December 31, 2019

$

(1,089)

$

(9)

$

(60)

$

(1,158)

Other comprehensive (loss) before reclassification adjustments

(105)

(50)

(155)

Loss reclassified from accumulated OCI

56

56

Tax (provision)

(2)

(2)

Net other comprehensive (loss) income

(105)

4

(101)

Balance, September 30, 2020

$

(1,194)

$

(5)

$

(60)

$

(1,259)

(in millions)

    

Cumulative Translation Adjustment

    

Hedging Activities

    

Pension and Postretirement Adjustment

    

Accumulated Other Comprehensive Loss

   

Balance, December 31, 2018

$

(1,080)

$

(5)

$

(69)

$

(1,154)

Other comprehensive (loss) before reclassification adjustments

(48)

(16)

(2)

(66)

Loss reclassified from accumulated OCI

3

3

Tax benefit

3

3

Net other comprehensive loss

(48)

(10)

(2)

(60)

Balance, September 30, 2019

$

(1,128)

$

(15)

$

(71)

$

(1,214)

Schedule of stockholders equity and redeemable equity

Total Equity

Non-

Accumulated

Redeemable

Share-based

Redeemable

Additional

Other

Non-

Payments

Non-

Preferred

Common

Paid-In

Treasury

Comprehensive

Retained

Controlling

Subject to

Controlling

(in millions)

  

Stock

  

Stock

  

Capital

  

Stock

  

Loss

  

Earnings

  

Interests

  

Redemption

  

Interests

 

Balance, December 31, 2019

$

$

1

$

1,137

$

(1,040)

$

(1,158)

$

3,780

$

21

$

31

$

Net income attributable to Ingredion

75

Net income attributable to non-controlling interests

3

Dividends declared, common stock ($0.63/share)

(42)

Share-based compensation, net of issuance

5

12

(8)

Other comprehensive loss

(164)

(3)

Balance, March 31, 2020

$

$

1

$

1,142

$

(1,028)

$

(1,322)

$

3,813

$

21

$

23

$

Net income attributable to Ingredion

66

Net income attributable to non-controlling interests

1

Dividends declared, common stock ($0.63/share)

(43)

Dividends declared, non-controlling interests

(3)

Share-based compensation, net of issuance

1

1

4

Other comprehensive income

15

1

Balance, June 30, 2020

$

$

1

$

1,143

$

(1,027)

$

(1,307)

$

3,836

$

20

$

27

$

Net income attributable to Ingredion

92

Net income attributable to non-controlling interests

3

(2)

Dividends declared, common stock ($0.64/share)

(44)

Dividends declared, non-controlling interests

(2)

Acquisition of redeemable non-controlling interests

74

Share-based compensation, net of issuance

2

5

Other comprehensive (loss) income

48

2

Balance, September 30, 2020

$

$

1

$

1,145

$

(1,027)

$

(1,259)

$

3,884

$

21

$

32

$

74

Total Equity

 

Non-

Accumulated 

Redeemable

Share-based

Redeemable

 

Additional

Other

Non-

Payments

Non-

Preferred

Common

Paid-In

Treasury

Comprehensive

Retained

Controlling

Subject to

Controlling

 

(in millions)

  

Stock

  

Stock

  

Capital

  

Stock

  

Loss

  

Earnings

  

Interests

  

Redemption

  

Interests

 

Balance, December 31, 2018

$

$

1

$

1,096

$

(1,091)

$

(1,154)

$

3,536

$

20

$

37

$

Net income attributable to Ingredion

100

Net income attributable to non-controlling interests

2

Dividends declared, common stock ($0.625/share)

(42)

Repurchases of common stock

32

31

Share-based compensation, net of issuance

9

10

(16)

Other comprehensive loss

(6)

Balance, March 31, 2019

$

$

1

$

1,137

$

(1,050)

$

(1,160)

$

3,594

$

22

$

21

$

Net income attributable to Ingredion

105

Net income attributable to non-controlling interests

2

Dividends declared, common stock ($0.625/share)

(43)

Dividends declared, non-controlling interests

(4)

Share-based compensation, net of issuance

1

3

4

Other comprehensive income (loss)

8

(4)

Balance, June 30, 2019

$

$

1

$

1,138

$

(1,047)

$

(1,152)

$

3,656

$

16

$

25

$

Net income attributable to Ingredion

99

Net income attributable to non-controlling interests

3

Dividends declared, common stock ($0.63/share)

(42)

Dividends declared, non-controlling interests

(2)

Repurchases of common stock

Share-based compensation, net of issuance

(1)

3

3

Other comprehensive (loss) income

(62)

2

Balance, September 30, 2019

$

$

1

$

1,137

$

(1,044)

$

(1,214)

$

3,713

$

19

$

28

$

Schedule of basic and diluted earnings per common share

    

Three Months Ended September 30, 2020

    

Three Months Ended September 30, 2019

    

(in millions, except per share amounts)

   

Net Income Available to Ingredion

    

Weighted Average Shares

    

Per Share Amount

    

Net Income Available to Ingredion

    

Weighted Average Shares

    

Per Share Amount

    

Basic EPS

$

92

 

67.2

$

1.37

$

99

 

66.9

$

1.48

Effect of Dilutive Securities:

Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards

 

0.4

 

0.5

Diluted EPS

$

92

 

67.6

$

1.36

$

99

 

67.4

$

1.47

    

Nine Months Ended September 30, 2020

    

Nine Months Ended September 30, 2019

    

(in millions, except per share amounts)

   

Net Income Available to Ingredion

    

Weighted Average Shares

    

Per Share Amount

    

Net Income Available to Ingredion

    

Weighted Average Shares

    

Per Share Amount

    

Basic EPS

$

233

 

67.2

$

3.47

$

304

 

66.9

$

4.54

Effect of Dilutive Securities:

Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards

 

0.4

 

0.5

Diluted EPS

$

233

 

67.6

$

3.45

$

304

 

67.4

$

4.51